Evidence map›Paper›PMID 32913908›Full record

ArticleHeliyon2020

Synthesis, antidiabetic, antioxidant and anti-inflammatory activities of novel hydroxytriazenes based on sulpha drugs.

Varsha Dayma, Jaishri Chopra, Poonam Sharma, Aparna Dwivedi, Indra P Tripathi, Amit Bhargava, Vanangamudi Murugesan, Ajay K Goswami, Prabhat K Baroliya

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. IUCrData · 2025
    Article
  2. Article
  3. Article
  4. Heliyon · 2023
    Article
  5. Article
  6. Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis,Journal of enzyme inhibition and medicinal chemistry · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Varsha DaymaDepartment of Chemistry, Mohanlal Sukhadia University, Udaipur, India.
Jaishri ChopraDepartment of Chemistry, Mohanlal Sukhadia University, Udaipur, India.
Poonam SharmaDepartment of Chemistry, Mohanlal Sukhadia University, Udaipur, India.
Aparna DwivediDepartment of Environmental Sciences, Mahatma Gandhi Gramoday Chitrakoot Vishwvidhyalay, Chitrakoot, Satna, India.
Indra P TripathiDepartment of Environmental Sciences, Mahatma Gandhi Gramoday Chitrakoot Vishwvidhyalay, Chitrakoot, Satna, India.
Amit BhargavaDepartment of Pharmacology and Toxicology Studies, Bhupal Noble Institute of Pharmaceutical Sciences, Udaipur, India.
Vanangamudi MurugesanDepartment of Medicinal and Pharmaceutical Chemistry, Sree Vidyanikethan College of Pharmacy, Tirupathi, India.
Ajay K GoswamiDepartment of Chemistry, Mohanlal Sukhadia University, Udaipur, India.
Prabhat K BaroliyaDepartment of Chemistry, Mohanlal Sukhadia University, Udaipur, India.
Mohanlal Sukhadia University · INMahatma Gandhi Chitrakoot Gramodaya Vishwavidyalaya · INInstitute of Physics, Bhubaneshwar · INSwami Vivekanand College of Pharmacy · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study is aimed to investigate the anti-inflammatory, antioxidant and antidiabetic activities of three series of hydroxytriazenes based on sulfa drugs viz; Sulphathiazole (ST), Sulfisoxazole (SF) and Sulphamethoxazole (SM). Antidiabetic activities of the synthesized hydroxytriazenes were investigated by α-glucosidase and α-amylase inhibition method and IC

Indexed as

Antidiabetic activityAnti-inflammatoryAntioxidantHydroxytriazenesMolecular dockingOrganic chemistryPharmaceutical chemistrySulpha drug

Identifiers

PMID32913908
PMCPMC7472862
OpenAlexW3082082902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.